First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.
BMJ Case Rep July 15, 2019 Ben Sessa, Chloe Sakal, Steve O’Brien et al. 55 citations
In a preliminary safety study of MDMA-assisted psychotherapy for alcohol use disorder, the first four participants tolerated the treatment without serious adverse events. The combination of MDMA with psychotherapy was feasible and acceptable, though the small number of participants limits conclusions about efficacy. These early results suggest that further research into this approach for alcohol dependence is warranted.